查詢結果分析
相關文獻
- The Prescribing Patterns of Antithrombotic Agents for Prevention of Recurrent Ischemic Stroke
- 以動脈注射血栓溶劑治療急性缺血性腦中風:七例報告
- 成功使用血栓溶解劑治療急性缺血性腦中風:一病例報告暨文獻回顧
- Cranial Computed Tomography in Ischemic Stroke Patients with and without Dementia--A Prospective Study
- Current Antithrombotic Therapy in Cardiac Disease
- 缺血性腦中風的治療
- Common Carotid Artery Thrombosis Causing Ischemic Stroke in a Patient with Systemic Lupus Erythematosus
- 使用血栓溶解劑治療急性缺血性腦中風--病例報告
- 頭部CT不見病變之急性缺血性腦中風--兼論腦缺血之急性誘因及治療
- 應用中文化中風量表評估急性缺血性腦中風患者可信度之研究
頁籤選單縮合
題 名 | The Prescribing Patterns of Antithrombotic Agents for Prevention of Recurrent Ischemic Stroke=抗血栓藥物用於預防缺血性腦中風再發之處方模式 |
---|---|
作 者 | 傅維仁; 林雅如; 薛一鴻; | 書刊名 | Acta Neurologica Taiwanica |
卷 期 | 18:2 2009.06[民98.06] |
頁 次 | 頁98-103 |
分類號 | 418.2325 |
關鍵詞 | 抗血栓藥物; 缺血性腦中風; Antithrombotic therapy; Antiplatelet agents; Recurrent stroke; Stroke prevention; |
語 文 | 英文(English) |
英文摘要 | Objectives: Antithrombotic agents are effective in the secondary prevention of ischemic strokes. In the present study, we sought to determine the antithrombotic prescribing patterns of neurologists in patients with first-ever ischemic stroke and also to identify the factors influencing the choice of a specific agent and what changes are made when a recurrent stroke occurs in these patients. Methods: We retrospectively reviewed the medical records of neurology patients who were diagnosed with first-ever ischemic stroke and were antithrombotic naïve from January 1, 2000 to December 31, 2000. Patients’ antithrombotic agents at discharge and during the follow-up period were reviewed to identify factors affecting the choice of antithrombotic agents. Results: A total of 376 patients experienced non-fatal first-ever ischemic stroke. Of these, 351 were prescribed antithrombotic agents at discharge, while the remaining 25 were not on antithrombotic treatment. Low-dose aspirin was the most commonly prescribed agent (65%). The most important determinant for the choice of other antiplatelet agents was aspirin intolerance. Not surprisingly, only 36% of the patients with atrial fibrillation were treated with oral anticoagulants at the time of hospital discharge. Conclusion: Aspirin remains the most commonly used antithrombotic agent for the prevention of recurrent stroke among antithrombotic naïve patients with a first-ever ischemic stroke in our institution. Our results demonstrate that current recommendations find their way into clinical practice, but to a limited extent. We aim that all patients discharged from our hospital after strokes must receive appropriate antithrombotic drugs for prevention of recurrent strokes provided if there are no contraindications to therapy. |
本系統中英文摘要資訊取自各篇刊載內容。